ICCC
ImmuCell Corporation (ICCC)
NASDAQ
ImmuCell Corporation annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ImmuCell Corporation revenue for the quarter ending March 31, 2026 was 10.4 M, a 28.39% increase year-over-year.
- ImmuCell Corporation revenue for the twelve months ending March 31, 2026 was 30.4 M, a 25.84% increase year-over-year.
- ImmuCell Corporation annual revenue for 2025 was 27.6 M, a 4.34% increase from 2024.
- ImmuCell Corporation annual revenue for 2024 was 26.5 M, a 51.64% increase from 2023.
- ImmuCell Corporation annual revenue for 2023 was 17.5 M, a 5.90% decrease from 2022.
- ImmuCell Corporation annual revenue for 2022 was 18.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImmuCell Corporation Earnings — FAQ
ImmuCell Corporation (ICCC) earnings over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's earnings history?
The chart and table above show ImmuCell Corporation's earnings by year and by quarter, including the growth rate.